Breaking News, Collaborations & Alliances

Chime Biologics, Kings Pharm Partner to Accelerate Biosimilar Launch

Chime will provide cell line development, process development, global GMP manufacturing, commercialization, and regulatory filing support.

Chime Biologics, a contract development and manufacturing organization (CDMO), is joining forces with Kings Pharm to provide cell line development, early process development, global clinical and commercial manufacturing, and registration services to Kings Pharm. Chime Biologics will be the exclusive service provider to help Kings Pharm bring its asset to global markets. Chime Biologics is launching global services for biosimilars to support clients biosimilar IND-filing, clinical sampling, co...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters